Critically examine the latest developments in the use of CAR T-cell therapies for the treatment of B-cell lymphomas, including incorporation into earlier lines of therapy. Discuss research directions for third- and fourth-generation CAR T-cell therapies. Formulate strategies that are tailored for patients being treated for B-cell lymphoma in the community setting, based on up-to-date research regarding sequencing, patient selection, and individual referral processes. Propose eìective approaches to recognize and manage adverse events among patients with B-cell lymphomas receiving CAR T-cell therapies in the community
- Provider:Medical Education Resources
- Activity Link: https://mycme.com
- Start Date: 2024-06-19 05:00:00
- End Date: 2024-06-19 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 45000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest